Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA) today announced the launch of Mozarc Medical—an independent new company committed to reshaping kidney health and driving patient-centered...
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on...
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter and year ended December 31, 2022. "We continue to have excitement and conviction in our long-term capabilities and...
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time....
Today, DaVita recognizes the impact its employees, known as teammates, had on kidney care in 2022. Over the last year, DaVita made strides in innovation and clinical excellence while uplifting the...